Update on pathogen inactivation treatment of plasma, with the INTERCEPT Blood System: Current position on methodological, clinical and regulatory aspects

Transfusion and Apheresis Science - Tập 52 - Trang 240-244 - 2015
Johannes Irsch1, Jerard Seghatchian2
1Cerus BV, Amersfoort, The Netherlands
2International Consultancy in Blood Components Quality/Safety Improvement, Audit/Inspection and DDR Strategy, London, UK

Tài liệu tham khảo